244 related articles for article (PubMed ID: 34058065)
21. Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer.
Lin H; Shi X; Li H; Hui J; Liu R; Chen Z; Lu Y; Tan W
BMC Cancer; 2021 Dec; 21(1):1293. PubMed ID: 34861847
[TBL] [Abstract][Full Text] [Related]
22. Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer.
Su YY; Sun L; Guo ZR; Li JC; Bai TT; Cai XX; Li WH; Zhu YF
J Ovarian Res; 2019 Jan; 12(1):6. PubMed ID: 30670062
[TBL] [Abstract][Full Text] [Related]
23. Plasma-derived exosomal miR-15a-5p as a promising diagnostic biomarker for early detection of endometrial carcinoma.
Zhou L; Wang W; Wang F; Yang S; Hu J; Lu B; Pan Z; Ma Y; Zheng M; Zhou L; Lei S; Song P; Liu P; Lu W; Lu Y
Mol Cancer; 2021 Mar; 20(1):57. PubMed ID: 33781255
[TBL] [Abstract][Full Text] [Related]
24. Circulating miR-30b-5p levels in plasma as a novel potential biomarker for early detection of breast cancer.
Adam-Artigues A; Garrido-Cano I; Simón S; Ortega B; Moragón S; Lameirinhas A; Constâncio V; Salta S; Burgués O; Bermejo B; Henrique R; Lluch A; Jerónimo C; Eroles P; Cejalvo JM
ESMO Open; 2021 Feb; 6(1):100039. PubMed ID: 33477007
[TBL] [Abstract][Full Text] [Related]
25. Plasma-derived exosomal miR-4732-5p is a promising noninvasive diagnostic biomarker for epithelial ovarian cancer.
Liu J; Yoo J; Ho JY; Jung Y; Lee S; Hur SY; Choi YJ
J Ovarian Res; 2021 Apr; 14(1):59. PubMed ID: 33910598
[TBL] [Abstract][Full Text] [Related]
26. Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma.
Que R; Ding G; Chen J; Cao L
World J Surg Oncol; 2013 Sep; 11():219. PubMed ID: 24007214
[TBL] [Abstract][Full Text] [Related]
27. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer.
Tsukamoto M; Iinuma H; Yagi T; Matsuda K; Hashiguchi Y
Oncology; 2017; 92(6):360-370. PubMed ID: 28376502
[TBL] [Abstract][Full Text] [Related]
28. A Signature of Four Circulating microRNAs as Potential Biomarkers for Diagnosing Early-Stage Breast Cancer.
Itani MM; Nassar FJ; Tfayli AH; Talhouk RS; Chamandi GK; Itani ARS; Makoukji J; Boustany RN; Hou L; Zgheib NK; Nasr RR
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34204158
[TBL] [Abstract][Full Text] [Related]
29. Detection significance of miR-3662, miR-146a, and miR-1290 in serum exosomes of breast cancer patients.
Li S; Zhang M; Xu F; Wang Y; Leng D
J Cancer Res Ther; 2021 Jul; 17(3):749-755. PubMed ID: 34269309
[TBL] [Abstract][Full Text] [Related]
30. Tumor-derived circulating exosomal miR-342-5p and miR-574-5p as promising diagnostic biomarkers for early-stage Lung Adenocarcinoma.
Han Z; Li Y; Zhang J; Guo C; Li Q; Zhang X; Lan Y; Gu W; Xing Z; Liang L; Li M; Mi S
Int J Med Sci; 2020; 17(10):1428-1438. PubMed ID: 32624699
[TBL] [Abstract][Full Text] [Related]
31. Exosomal miRNAs as circulating biomarkers for prediction of development of haematogenous metastasis after surgery for stage II/III gastric cancer.
Liu X; Chu KM
J Cell Mol Med; 2020 Jun; 24(11):6220-6232. PubMed ID: 32383554
[TBL] [Abstract][Full Text] [Related]
32. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
[TBL] [Abstract][Full Text] [Related]
33. Circulating Exosomal miRNAs as Novel Biomarkers for Stable Coronary Artery Disease.
Zhang P; Liang T; Chen Y; Wang X; Wu T; Xie Z; Luo J; Yu Y; Yu H
Biomed Res Int; 2020; 2020():3593962. PubMed ID: 33381550
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer.
Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H
Oncotarget; 2016 Mar; 7(13):16923-35. PubMed ID: 26943577
[TBL] [Abstract][Full Text] [Related]
35. Tumor-derived exosomal miRNA-320d as a biomarker for metastatic colorectal cancer.
Tang Y; Zhao Y; Song X; Song X; Niu L; Xie L
J Clin Lab Anal; 2019 Nov; 33(9):e23004. PubMed ID: 31420913
[TBL] [Abstract][Full Text] [Related]
36. Hypoxic tumor-derived exosomal miR-31-5p promotes lung adenocarcinoma metastasis by negatively regulating SATB2-reversed EMT and activating MEK/ERK signaling.
Yu F; Liang M; Huang Y; Wu W; Zheng B; Chen C
J Exp Clin Cancer Res; 2021 Jun; 40(1):179. PubMed ID: 34074322
[TBL] [Abstract][Full Text] [Related]
37. Urinary exosomal microRNA-96-5p and microRNA-183-5p expression as potential biomarkers of bladder cancer.
El-Shal AS; Shalaby SM; Abouhashem SE; Elbary EHA; Azazy S; Rashad NM; Sarhan W
Mol Biol Rep; 2021 May; 48(5):4361-4371. PubMed ID: 34085193
[TBL] [Abstract][Full Text] [Related]
38. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
[TBL] [Abstract][Full Text] [Related]
39. Exosome-transmitted microRNA-133b inhibited bladder cancer proliferation by upregulating dual-specificity protein phosphatase 1.
Cai X; Qu L; Yang J; Xu J; Sun L; Wei X; Qu X; Bai T; Guo Z; Zhu Y
Cancer Med; 2020 Aug; 9(16):6009-6019. PubMed ID: 32627968
[TBL] [Abstract][Full Text] [Related]
40. The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers.
Chen W; Cai F; Zhang B; Barekati Z; Zhong XY
Tumour Biol; 2013 Feb; 34(1):455-62. PubMed ID: 23238818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
